Yvonne Morrison

604 total citations
16 papers, 310 citations indexed

About

Yvonne Morrison is a scholar working on Transplantation, Surgery and Biomedical Engineering. According to data from OpenAlex, Yvonne Morrison has authored 16 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Transplantation, 11 papers in Surgery and 4 papers in Biomedical Engineering. Recurrent topics in Yvonne Morrison's work include Renal Transplantation Outcomes and Treatments (13 papers), Transplantation: Methods and Outcomes (7 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Yvonne Morrison is often cited by papers focused on Renal Transplantation Outcomes and Treatments (13 papers), Transplantation: Methods and Outcomes (7 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Yvonne Morrison collaborates with scholars based in United States, Canada and Sweden. Yvonne Morrison's co-authors include Nancy D. Bridges, David Iklé, Brian Armstrong, Peter S. Heeger, Barry L. Warshaw, Roslyn B. Mannon, Mark R. Benfield, Sharon Bartosh, W. Harmon and Aneesh K. Mehta and has published in prestigious journals such as Transplantation, American Journal of Transplantation and The Journal of Heart and Lung Transplantation.

In The Last Decade

Yvonne Morrison

16 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yvonne Morrison United States 12 224 209 50 43 40 16 310
P. Gombos Germany 8 228 1.0× 172 0.8× 55 1.1× 37 0.9× 6 0.1× 10 289
Mohammad Amin Abbasi Iran 11 97 0.4× 88 0.4× 51 1.0× 45 1.0× 6 0.1× 41 308
A. Osama Gaber United States 8 329 1.5× 322 1.5× 73 1.5× 19 0.4× 7 0.2× 8 451
P.G.P Machado Brazil 12 231 1.0× 133 0.6× 63 1.3× 38 0.9× 7 0.2× 29 343
Shruti Mittal United Kingdom 13 248 1.1× 300 1.4× 105 2.1× 23 0.5× 9 0.2× 33 393
S. See Tai United States 5 271 1.2× 187 0.9× 34 0.7× 15 0.3× 8 0.2× 6 406
Münci Kalayoğlu United States 9 230 1.0× 397 1.9× 191 3.8× 24 0.6× 14 0.3× 10 533
D'Alessandro Am United States 13 135 0.6× 374 1.8× 112 2.2× 18 0.4× 7 0.2× 34 446
H. J. Schlitt Germany 7 89 0.4× 177 0.8× 32 0.6× 8 0.2× 9 0.2× 20 272
O'Connell Jb United States 10 99 0.4× 215 1.0× 7 0.1× 18 0.4× 74 1.9× 19 300

Countries citing papers authored by Yvonne Morrison

Since Specialization
Citations

This map shows the geographic impact of Yvonne Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvonne Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvonne Morrison more than expected).

Fields of papers citing papers by Yvonne Morrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvonne Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvonne Morrison. The network helps show where Yvonne Morrison may publish in the future.

Co-authorship network of co-authors of Yvonne Morrison

This figure shows the co-authorship network connecting the top 25 collaborators of Yvonne Morrison. A scholar is included among the top collaborators of Yvonne Morrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvonne Morrison. Yvonne Morrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Webber, Steven A., Hyunsook Chin, James D. Wilkinson, et al.. (2023). Impact of donor-specific anti-HLA antibody on cardiac hemodynamics and graft function 3 years after pediatric heart transplantation: First results from the CTOTC-09 multi-institutional study. American Journal of Transplantation. 23(12). 1893–1907. 3 indexed citations
2.
Stock, Peter G., Roslyn B. Mannon, Brian Armstrong, et al.. (2020). Challenges of calcineurin inhibitor withdrawal following combined pancreas and kidney transplantation: Results of a prospective, randomized clinical trial. American Journal of Transplantation. 20(6). 1668–1678. 18 indexed citations
3.
Mannon, Roslyn B., Brian Armstrong, Peter G. Stock, et al.. (2020). Avoidance of CNI and steroids using belatacept—Results of the Clinical Trials in Organ Transplantation 16 trial. American Journal of Transplantation. 20(12). 3599–3608. 20 indexed citations
4.
Lamour, Jacqueline M., Daphne T. Hsu, Brian Feingold, et al.. (2019). Early outcomes for low-risk pediatric heart transplant recipients and steroid avoidance: A multicenter cohort study (Clinical Trials in Organ Transplantation in Children - CTOTC-04). The Journal of Heart and Lung Transplantation. 38(9). 972–981. 11 indexed citations
5.
Webber, Steven A., Adriana Zeevi, Linda J. Addonizio, et al.. (2018). Pediatric heart transplantation across a positive crossmatch: First year results from the CTOTC-04 multi-institutional study. American Journal of Transplantation. 18(9). 2148–2162. 29 indexed citations
6.
Dipchand, Anne I., Steven A. Webber, Brian Feingold, et al.. (2018). Incidence, characterization, and impact of newly detected donor-specific anti-HLA antibody in the first year after pediatric heart transplantation: A report from the CTOTC-04 study. American Journal of Transplantation. 18(9). 2163–2174. 26 indexed citations
7.
Stehlik, Josef, Brian Armstrong, David A. Baran, et al.. (2018). Early immune biomarkers and intermediate-term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation-18. American Journal of Transplantation. 19(5). 1518–1528. 12 indexed citations
8.
Zur‐Mühlen, Bengt von, Torbjörn Lundgren, Levent Bayman, et al.. (2018). Open Randomized Multicenter Study to Evaluate Safety and Efficacy of Low Molecular Weight Sulfated Dextran in Islet Transplantation. Transplantation. 103(3). 630–637. 27 indexed citations
9.
Newell, K.A., Aneesh K. Mehta, Christian P. Larsen, et al.. (2017). Lessons Learned: Early Termination of a Randomized Trial of Calcineurin Inhibitor and Corticosteroid Avoidance Using Belatacept. American Journal of Transplantation. 17(10). 2712–2719. 24 indexed citations
10.
Nadkarni, Girish N., Nancy D. Bridges, Jens Goebel, et al.. (2017). Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes. Transplantation. 102(4). 673–680. 31 indexed citations
11.
Asare, Adam L., Sai Kanaparthi, Noha Lim, et al.. (2017). B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function. American Journal of Transplantation. 17(10). 2627–2639. 18 indexed citations
12.
Dipchand, Anne I., Brian Feingold, Carol Bentlejewski, et al.. (2017). Impact of Newly Detected Donor Specific Anti-HLA Antibody in the First Year After Pediatric Heart Transplantation. The Journal of Heart and Lung Transplantation. 36(4). S78–S78. 1 indexed citations
13.
Starling, R.C., Josef Stehlik, David A. Baran, et al.. (2015). Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study. American Journal of Transplantation. 16(1). 121–136. 45 indexed citations
14.
Morrison, Yvonne, Lindsay Wilson, Fiona Kelly, et al.. (2013). Assessment of outcome in clinical trials in mild Alzheimer�s disease: Urgent time for a rethink?. 1(1). 2 indexed citations
15.
Benfield, Mark R., Sharon Bartosh, David Iklé, et al.. (2009). A Randomized Double‐Blind, Placebo Controlled Trial of Steroid Withdrawal after Pediatric Renal Transplantation. American Journal of Transplantation. 10(1). 81–88. 42 indexed citations
16.
Morrison, Yvonne. (2004). Down In The Forest. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Gombos Breakdown of academic impact, for papers by Mohammad Amin Abbasi Breakdown of academic impact, for papers by A. Osama Gaber Breakdown of academic impact, for papers by P.G.P Machado Breakdown of academic impact, for papers by Shruti Mittal Breakdown of academic impact, for papers by S. See Tai Breakdown of academic impact, for papers by Münci Kalayoğlu Breakdown of academic impact, for papers by D'Alessandro Am Breakdown of academic impact, for papers by H. J. Schlitt Breakdown of academic impact, for papers by O'Connell Jb
Rankless by CCL
2026